Irish Journal of Medical Science (1971 -)

, Volume 184, Issue 2, pp 305–311

Active surveillance for low-risk prostate cancer: diversity of practice across Europe

  • A. Azmi
  • R. A. Dillon
  • S. Borghesi
  • M. Dunne
  • R. E. Power
  • L. Marignol
  • B. D. P. O’Neill
Original Article

DOI: 10.1007/s11845-014-1104-5

Cite this article as:
Azmi, A., Dillon, R.A., Borghesi, S. et al. Ir J Med Sci (2015) 184: 305. doi:10.1007/s11845-014-1104-5
  • 151 Downloads

Abstract

Background

Active surveillance (AS) is a recognised treatment option for low-risk prostate cancer (PCa).

Aims

To review AS criteria in terms of patient selection, follow-up and indications for intervention.

Methods

A total of 2,959 potential participants were identified and invited via email to complete an online survey. Only urologists practising in an EU country were eligible to participate. Statistical analyses were carried out using SPSS version 18.0. The χ2 test was used to compare responses between those who do and do not follow an AS protocol.

Results

Response rate was 8 % (n = 226). Ninety-seven per cent urologists offer AS; 25 % (n = 53/215) within a clinical trial and a further 28 % (n = 60/215) using an official AS protocol. Gleason score ≤ 3 + 3 = 6 (87 %, n = 173/200) and prostate-specific antigen (PSA) ≤ 10 ng/ml (86 %, n = 170/198) are the commonest selection criteria. There was a statistically significant association between having an AS protocol and using PSA as an eligibility criterion (p = 0.03). For urologists not following a protocol, 11 % do not consider PSA as an eligibility criterion and 81 % consider PSA ≤ 10 ng/ml to decide on AS, compared to 2 and 90 %, respectively, who adhere to a protocol. Twenty-four per cent of urologists without a protocol do not re-biopsy in comparison to 11 % with a protocol (p = 0.026). Gleason score progression trigger the most intervention (n = 168/192, 87 %).

Conclusions

Urologists not adhering to an AS protocol or participating in a clinical trial appear to apply less rigorous criteria for both eligibility and monitoring in AS.

Keywords

Active surveillance Low-risk prostate cancer Survey Protocol Triggers for intervention Rebiopsy 

Copyright information

© Royal Academy of Medicine in Ireland 2014

Authors and Affiliations

  • A. Azmi
    • 1
  • R. A. Dillon
    • 2
  • S. Borghesi
    • 3
  • M. Dunne
    • 4
  • R. E. Power
    • 5
  • L. Marignol
    • 2
  • B. D. P. O’Neill
    • 1
  1. 1.St. Luke’s Radiation Oncology CentreBeaumont HospitalDublinIreland
  2. 2.Division of Radiation TherapyTrinity College DublinDublinIreland
  3. 3.Radiotherapy UnitSan Donato HospitalArezzoItaly
  4. 4.Clinical Trials UnitSt. Luke’s HospitalDublinIreland
  5. 5.Department of UrologyBeaumont HospitalDublinIreland

Personalised recommendations